Grant: Operating Grant
University of Toronto
$177,589.00
Neurocognitive Intermediate Phenotypes in Borderline Personality Disorder: A Family Study
FY 2011-12
Summary
Borderline personality disorder (BPD) is a serious form of mental illness associated with chronic suicidality, severe mood fluctuations, and dangerous impulsive behaviours. Efforts to understand the neurobiological causes of BPD have met with limited success. This is because BPD represents a heterogeneous clinical disorder comprised of multiple complex symptoms and traits which may be supported by distinct neurobiological systems. Identification of intermediate phenotypes, or biological liability markers, of BPD may help unravel the diverse causes of this illness. The goal of this research is to isolate the most promising intermediate phenotypes for BPD in patients and their first-degree relatives who are at increased genetic risk for the illness, and comparing them with individuals with no personal or family history of mental illness. Participants will complete cognitive tests (e.g., memory, concentration) and brain imaging procedures using functional near-infrared spectroscopy to probe areas of the frontal cortex responsible for impulse control. We anticipate that patients and their relatives will show deficits on cognitive testing and decreased activation of the frontal cortex on brain imaging, lending support to these measures as putative intermediate phenotypes for BPD. The results of this study have the potential to improve the future care of these patients in a number of ways. First, this work will help characterize neurobiological abnormalities in BPD patients and their relatives, paving the way for biological tests to identify individuals at risk for BPD and focus efforts at early intervention and prevention. Second, these results will aid in parsing the heterogeneous presentation of BPD, helping to direct treatments that target subsets of patients with specific biological vulnerabilities. Finally, the discovery of intermediate phenotypes for BPD will help construct the road-map for isolating which genes confer susceptibility to this devastating illness.
Department
Program
Operating Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
253499
Name
Ruocco Anthony C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Behavioural Sciences - B: Clinical Behavioural Sciences
Projecttitle
Neurocognitive Intermediate Phenotypes in Borderline Personality Disorder: A Family Study
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$177,589
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Borderline Personality Disorder; Functional Near-Infrared Spectroscopy; Intermediate Phenotypes; Neuropsychology
Abstract
Borderline personality disorder (BPD) is a serious form of mental illness associated with chronic suicidality, severe mood fluctuations, and dangerous impulsive behaviours. Efforts to understand the neurobiological causes of BPD have met with limited success. This is because BPD represents a heterogeneous clinical disorder comprised of multiple complex symptoms and traits which may be supported by distinct neurobiological systems. Identification of intermediate phenotypes, or biological liability markers, of BPD may help unravel the diverse causes of this illness. The goal of this research is to isolate the most promising intermediate phenotypes for BPD in patients and their first-degree relatives who are at increased genetic risk for the illness, and comparing them with individuals with no personal or family history of mental illness. Participants will complete cognitive tests (e.g., memory, concentration) and brain imaging procedures using functional near-infrared spectroscopy to probe areas of the frontal cortex responsible for impulse control. We anticipate that patients and their relatives will show deficits on cognitive testing and decreased activation of the frontal cortex on brain imaging, lending support to these measures as putative intermediate phenotypes for BPD. The results of this study have the potential to improve the future care of these patients in a number of ways. First, this work will help characterize neurobiological abnormalities in BPD patients and their relatives, paving the way for biological tests to identify individuals at risk for BPD and focus efforts at early intervention and prevention. Second, these results will aid in parsing the heterogeneous presentation of BPD, helping to direct treatments that target subsets of patients with specific biological vulnerabilities. Finally, the discovery of intermediate phenotypes for BPD will help construct the road-map for isolating which genes confer susceptibility to this devastating illness.
Competitiondate
201203
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Ruocco, Anthony C; Bagby, Robert M
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $177,589~ $0~